» Articles » PMID: 26105042

Hyperparathyroidism and Bone Health

Overview
Publisher Current Science
Specialty Rheumatology
Date 2015 Jun 25
PMID 26105042
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Bone pain, proximal muscle weakness, skeletal deformities, and pathological fractures are features of osteitis fibrosa cystica which occur in severe primary hyperparathyroidism (PHPT). In this condition, bone mineral density is usually extremely low, but may be reversible after parathyroidectomy. On X-ray, bone abnormalities are described as having a salt-and-pepper appearance in the skull, with bone erosions and resorption of the phalanges, brown tumors and cysts, as well as diffuse demineralization, along with pathological fractures, particularly in the long bones of the extremities. A marked elevation of the serum calcium and PTH concentrations is seen, and renal involvement is manifested by nephrolithiasis and nephrocalcinosis. In asymptomatic PHPT, the absence of clinically significant bone involvement has led to much more data on bone mineral density becoming available by dual X-ray absorptiometry (DXA) and also on new technologies such as trabecular bone score (TBS), which is a gray-level textural analysis of DXA images that provides an indirect index of trabecular microarchitecture. In addition, high-resolution peripheral computed tomography (HRpQCT), which has a low radiation exposure, provides further understanding of the microstructural skeletal features at both trabecular and cortical sites.

Citing Articles

Brown Tumors: The Hidden Face of Primary and Renal Hyperparathyroidism Amid Real-Life Settings.

Carsote M, Ciobica M, Sima O, Valea A, Bondor C, Geleriu A J Clin Med. 2024; 13(13).

PMID: 38999413 PMC: 11242279. DOI: 10.3390/jcm13133847.


Unraveling the relationship between serum parathyroid hormone levels and trabecular bone score: a cross-sectional study.

Zhao T, Li Y, Tian J, Kang Y, Xu J, Shao H Sci Rep. 2024; 14(1):13065.

PMID: 38844829 PMC: 11156926. DOI: 10.1038/s41598-024-63979-9.


Hypopituitarism due to a Large Osteoclastoma Arising from the Sphenoid Bone Invading the Pituitary Fossa in a Patient with Parathyroid Carcinoma.

Bandeira L, de Oliveira L, de Lima M, Rego D, Griz L, Bandeira F Case Rep Endocrinol. 2023; 2023:8274108.

PMID: 38156081 PMC: 10754633. DOI: 10.1155/2023/8274108.


Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report.

Legault O, Inman M, Moolman N, Wiebe S, Poulin A, Nour M BMC Pediatr. 2020; 20(1):547.

PMID: 33278878 PMC: 7718669. DOI: 10.1186/s12887-020-02445-7.


Changes in bone mineral density after parathyroidectomy in patients with moderate to severe primary hyperparathyroidism.

Lu S, Gong M, Zha Y, Cui A, Chen C, Yang H J Int Med Res. 2020; 48(10):300060520964698.

PMID: 33135515 PMC: 7780563. DOI: 10.1177/0300060520964698.


References
1.
Silva B, Boutroy S, Zhang C, McMahon D, Zhou B, Wang J . Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2013; 98(5):1963-70. PMC: 3644593. DOI: 10.1210/jc.2012-4255. View

2.
Hans D, Goertzen A, Krieg M, Leslie W . Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res. 2011; 26(11):2762-9. DOI: 10.1002/jbmr.499. View

3.
Zhao L, Liu J, He X, Zhao H, Sun L, Tao B . The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab. 2013; 98(2):721-8. DOI: 10.1210/jc.2012-2914. View

4.
Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri F, Morelli V, Zhukouskaya V . Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol. 2013; 169(2):155-62. DOI: 10.1530/EJE-13-0305. View

5.
Graal M, Wolffenbuttel B . Consequences of long-term hyperparathyroidism. Neth J Med. 1998; 53(1):37-42. DOI: 10.1016/s0300-2977(98)00010-2. View